129 related articles for article (PubMed ID: 38335663)
1. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
Agrawal T; Maddileti S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
Vincent A; Krishnakumar S; Parameswaran S
Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
[TBL] [Abstract][Full Text] [Related]
6. Mutational screening of germline
Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human induced pluripotent stem cell line (VRFi001-A) from orbital adipose tissue of a bilateral retinoblastoma patient with heterozygous RB1 gene deletion.
Vincent A; Khetan V; Rishi P; Suganeswari G; Krishnakumar S; Krishnan UM; Parameswaran S
Stem Cell Res; 2018 May; 29():42-45. PubMed ID: 29579639
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of two induced pluripotent stem cell lines from conjunctiva of a retinoblastoma patient.
Xu P; Guo F; Xiao W; Wang Y; Ye K; Mao Y; Zhong X
Stem Cell Res; 2023 Oct; 72():103200. PubMed ID: 37708614
[TBL] [Abstract][Full Text] [Related]
11. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
[TBL] [Abstract][Full Text] [Related]
12. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
16.
Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
[No Abstract] [Full Text] [Related]
17. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
18. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.
Tu J; Huo Z; Yu Y; Zhu D; Xu A; Huang MF; Hu R; Wang R; Gingold JA; Chen YH; Tsai KL; Forcioli-Conti NR; Huang SXL; Webb TR; Su J; Bazer DA; Jia P; Yustein JT; Wang LL; Hung MC; Zhao Z; Huff CD; Shen J; Zhao R; Lee DF
Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117857119. PubMed ID: 35412907
[TBL] [Abstract][Full Text] [Related]
19. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
Avior Y; Lezmi E; Yanuka D; Benvenisty N
Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
[TBL] [Abstract][Full Text] [Related]
20. Novel insights into RB1 mutation.
Yao Y; Gu X; Xu X; Ge S; Jia R
Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
